Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide Treatment IND for VOD
NCT00628498Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2007
- Primary completion
- Jul 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of defibrotide in hepatic veno-occlusive disease (HVOD), sponsored by Jazz Pharmaceuticals plc. Started Dec 2007; status: completed.
02
Drugs
defibrotide
03
Conditions
hepatic veno-occlusive disease (HVOD)
Beyond the preview
Go deeper on NCT00628498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628498.